Active - Proposal to Strike off11461695Private limited companyLondon

METACEUTICAL TECHNOLOGIES LIMITED

Significant control: Kenneth Richard Benning (25–50%), Kenneth Richard Benning (25–50%)

Proposal to strike offThe registrar has published a notice proposing to remove this company from the register. Unless the cause is dealt with or an objection is upheld, it can be dissolved. Status as shown on the Companies House register at 31 August 2026; it may have changed since. Check the live record.

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Metaceutical Technologies Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Metaceutical Technologies Limited sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy

Summary

Generated from filed data · no estimates

METACEUTICAL TECHNOLOGIES LIMITED is an active (proposal to strike off) private limited company (company number 11461695) incorporated on 12 July 2018, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Accounts are on file at Companies House (dormant) but not yet parsed into this record.

There are 603 companies in research and experimental development on biotechnology in London with filed accounts; the median reports net assets of £440 and is 6 years old.

Ownership and control

2 active

KR
Mr Kenneth Richard Benning
Individual · since 12 July 2018
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
25–50%
KR
Mr Kenneth Richard Benning
Individual · since 12 July 2018
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
25–50%

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

Key dates

Incorporated: 12 July 20188 yrs ago
First accounts due: 12 April 20202387 days overdue
Confirmation statement due: 26 July 2027in 274 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 72110: Research and experimental development on biotechnology
Accounts type: Dormant

Financials

No accounts on record

Accounts exist on the register but their figures are not in this dataset yet.

Filing and accounts signals

Facts from the register · no rating

Incorporated five or more years agoIncorporated 12 July 2018
Register status is not ActiveActive - Proposal to Strike off

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

Timeline

Newest first

26 Jul 2027Confirmation statement duein 274 days
12 Apr 2020First accounts due2387 days overdue
12 Jul 2018Incorporated

Similar companies in London

Same activity (research and experimental development on biotechnology), closest in incorporation date

All companies incorporated on 12 July 2018 · in Jul 2018.

Reminders for METACEUTICAL TECHNOLOGIES LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.